Wolf J - Search Results

1

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).

Bennet BM, Wolf J, Laureano R, Sellers RS. Bennet BM, et al. Among authors: wolf j. Toxicol Pathol. 2020 Oct;48(7):800-809. doi: 10.1177/0192623320959090. Epub 2020 Sep 14. Toxicol Pathol. 2020. PMID: 32926660 Review.

2

Scientific and Regulatory Policy Committee Points to Consider*: Approaches to the Conduct and Interpretation of Vaccine Safety Studies for Clinical and Anatomic Pathologists.

Sellers RS, Nelson K, Bennet B, Wolf J, Tripathi N, Chamanza R, Perron Lepage MF, Adkins K, Laurent S, Troth SP. Sellers RS, et al. Among authors: wolf j. Toxicol Pathol. 2020 Feb;48(2):257-276. doi: 10.1177/0192623319875085. Epub 2019 Oct 8. Toxicol Pathol. 2020. PMID: 31594486

3

The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.

Wolf J, Hansen R, Hassis K, Lapps W, Warmuth E. Wolf J, et al. Vaccine. 2020 Oct 27;38(46):7198-7200. doi: 10.1016/j.vaccine.2020.09.057. Epub 2020 Oct 5. Vaccine. 2020. PMID: 33032845 Free PMC article. No abstract available.

4

Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.

Coller BG, Blue J, Das R, Dubey S, Finelli L, Gupta S, Helmond F, Grant-Klein RJ, Liu K, Simon J, Troth S, VanRheenen S, Waterbury J, Wivel A, Wolf J, Heppner DG, Kemp T, Nichols R, Monath TP. Coller BG, et al. Among authors: wolf j. Vaccine. 2017 Aug 16;35(35 Pt A):4465-4469. doi: 10.1016/j.vaccine.2017.05.097. Epub 2017 Jun 21. Vaccine. 2017. PMID: 28647166

5

Application of PCR technology in vaccine product development.

Wolf JJ, Wang L, Wang F. Wolf JJ, et al. Expert Rev Vaccines. 2007 Aug;6(4):547-58. doi: 10.1586/14760584.6.4.547. Expert Rev Vaccines. 2007. PMID: 17669009 Review.

6

Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens.

Wolf J, Bruno S, Eichberg M, Jannat R, Rudo S, VanRheenen S, Coller BA. Wolf J, et al. NPJ Vaccines. 2020 Jun 15;5(1):51. doi: 10.1038/s41541-020-0204-7. eCollection 2020. NPJ Vaccines. 2020. PMID: 32566261 Free PMC article. Review.

7

[No title available]

[No authors listed] [No authors listed] PMID: 33580080

8

Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease.

Tell JG, Coller BG, Dubey SA, Jenal U, Lapps W, Wang L, Wolf J. Tell JG, et al. Among authors: wolf j. Vaccines (Basel). 2020 Dec 19;8(4):779. doi: 10.3390/vaccines8040779. Vaccines (Basel). 2020. PMID: 33352786 Free PMC article. Review.

9

Nonclinical safety assessment of vaccines and adjuvants.

Wolf JJ, Kaplanski CV, Lebron JA. Wolf JJ, et al. Methods Mol Biol. 2010;626:29-40. doi: 10.1007/978-1-60761-585-9_3. Methods Mol Biol. 2010. PMID: 20099119 Review.

10

Development of Pandemic Vaccines: ERVEBO Case Study.

Wolf J, Jannat R, Dubey S, Troth S, Onorato MT, Coller BA, Hanson ME, Simon JK. Wolf J, et al. Vaccines (Basel). 2021 Feb 25;9(3):190. doi: 10.3390/vaccines9030190. Vaccines (Basel). 2021. PMID: 33668698 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,387 results

Search Page